SPEC-AA (Stanford Pragmatic Effectiveness Comparison - Anticonvulsant vs Antidepressant)

The code block below illustrates how one might use # and // as comments in your logic and calculations.

This value you provided is not a number. Please try again.

This value you provided is not an integer. Please try again.

The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again.

The value you provided must be within the suggested range

The value you provided is outside the suggested range

This value is admissible, but you may wish to double check it.

The value entered must be a time value in the following format HH:MM within the range 00:00-23:59 (e.g., 04:32 or 23:19).

This field must be a 5 or 9 digit U.S. ZIP Code (like 94043). Please re-enter it now.

This field must be a 10 digit North American phone number (like 415 555 1212). Please re-enter it now.

This field must be a valid email address (like joe@user.com). Please re-enter it now.

The value you provided could not be validated because it does not follow the expected format. Please try again.

Required format:

9GTxJTJMR7EGNkSBzaQLmcENjMVFZ4ynwFdGMLDRAH6ELvRfdMVQfjaL4au6yaZkAHHJAcUFieoyKG4J5wvUMx9QgTtnG

Disclaimer:

"The purpose of the following screening survey is to confirm if you meet the criteria for taking part in our research study comparing antiseizure and antidepressant medication in treating chronic pain. We ask that you answer a few questions as accurately as possible: this will help us confirm if you are eligible for the study. If you are eligible for the study, we will provide more details about the study so you can decide whether you are interested in participating.

This screening survey is intended to be brief, taking a few minutes. You may choose not to answer any or all of the questions. There is no penalty for not completing the questions.

The information you provide will be kept as confidential as possible as required by law. It is possible that the Food and Drug Administration, and other federal and state authorities, may inspect this record. There is a small risk that people outside our research team could learn this information, but we do our best to keep all your information confidential.

If you are not eligible or interested in this study - you can choose to be included in our database to be contacted about future research studies. If you decide you do not want to participate in this study or future studies, you can request that we destroy the information we collect.

If you have any questions, concerns, or complaints about this survey, please let us know or contact the research director, Dr. Vafi Salmasi, at 650-725-0246.

If you want to talk to someone separate from the research team about a concern or complaint or your rights as a possible research participant, please contact the Stanford Institutional Review Board (IRB) to speak to an informed person who is separate from the research team, at 650-723-5244 (for medical studies), or toll-free at 1-866-680-2906. In addition, please call the Stanford IRB at these numbers if you cannot reach the research team."

Stanford is studying two types of medicine used to treat chronic pain: Anticonvulsants and Antidepressants. Doctors often use these medicines for pain, and we want to see how well they work for different people.

In this study, you will be chosen at random to get either an anticonvulsant or an antidepressant, kind of like flipping a coin. You have an equal chance to get either one. This study is also pragmatic, meaning we try to keep your usual healthcare routine. So, you and your doctor will pick the best medicine for you from the type you're assigned.

Your Participation

- After randomization, you will continue the medication for 6 months.

- We will prescribe the medication directly to your pharmacy.

- You will complete an online baseline survey at the time of enrollment (about 45 minutes).

- You will complete 3 total surveys during the study period (about 5 minutes).

- You will meet with a pain physician to guide treatment after each survey. We will use the information from the survey to best tailor the treatment plan for you.

Benefits

- You will have access to guided treatment plan with a pain physician for 6 months, with a total of 4 visits.

Eligibility

- Age > 18 years old

- Chronic pain persisting for more than 6 months

- Not being pregnant or planning to become pregnant during the course of the study

- Willing to take either an anticonvulsant or antidepressant medication for 6 months

- Living in California

Please complete the survey below.

Thank you!

You have selected an option that triggers this survey to end right now.

To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.